{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T22:12:15Z","timestamp":1792188735576,"version":"4.4.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2006,6,1]],"date-time":"2006-06-01T00:00:00Z","timestamp":1149120000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,6,1]],"date-time":"2006-06-01T00:00:00Z","timestamp":1149120000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,8]],"date-time":"2022-06-08T00:00:00Z","timestamp":1654646400000},"content-version":"vor","delay-in-days":5851,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","exphem.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Hematology"],"published-print":{"date-parts":[[2006,6]]},"DOI":"10.1016\/j.exphem.2006.03.002","type":"journal-article","created":{"date-parts":[[2006,6,8]],"date-time":"2006-06-08T14:17:16Z","timestamp":1149776236000},"page":"713-720","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":114,"title":["Oncolytic measles virus targets high CD46 expression on multiple myeloma cells"],"prefix":"10.1016","volume":"34","author":[{"given":"Hooi Tin","family":"Ong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael M.","family":"Timm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip R.","family":"Greipp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas E.","family":"Witzig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Dispenzieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen J.","family":"Russell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kah-Whye","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.exphem.2006.03.002_bib1","first-page":"8","article-title":"Cancer statistics, 2004","volume":"54","author":"Jemal","year":"2004","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.exphem.2006.03.002_bib2","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/S0140-6736(04)15736-X","article-title":"Multiple myeloma","volume":"363","author":"Sirohi","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.exphem.2006.03.002_bib3","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/S0037-1963(01)90014-9","article-title":"Randomized trial experience of the Intergoupe Francophone du Myelome","volume":"38","author":"Attal","year":"2001","journal-title":"Semin Hematol"},{"key":"10.1016\/j.exphem.2006.03.002_bib4","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0037-1963(01)90013-7","article-title":"European Group for Blood and Marrow Transplantation Registry studies in multiple myeloma","volume":"38","author":"Bjorkstrand","year":"2001","journal-title":"Semin Hematol"},{"key":"10.1016\/j.exphem.2006.03.002_bib5","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0037-1963(01)90015-0","article-title":"Results of high-dose treatment with autologous stem cell support in patients with multiple myeloma","volume":"38","author":"Fassas","year":"2001","journal-title":"Semin Hematol"},{"key":"10.1016\/j.exphem.2006.03.002_bib6","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1182\/blood.V98.7.2002","article-title":"Systemic therapy of myeloma xenografts by an attenuated measles virus","volume":"98","author":"Peng","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2006.03.002_bib7","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1038\/35022579","article-title":"SLAM (CDw150) is a cellular receptor for measles virus","volume":"406","author":"Tatsuo","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2006.03.002_bib8","doi-asserted-by":"crossref","unstructured":"Dorig RE, Marcil A, Chopra A, Richardson CD. The human CD46 molecule is a receptor for measles virus (Edmonston strain). Cell. 1993;75:295\u2013305.","DOI":"10.1016\/0092-8674(93)80071-L"},{"key":"10.1016\/j.exphem.2006.03.002_bib9","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1182\/blood-2003-07-2233","article-title":"Image-guided radiovirotherapy for multiple myeloma using a recombinant measles virus expressing the thyroidal sodium iodide symporter","volume":"103","author":"Dingli","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2006.03.002_bib10","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.bbrc.2005.08.261","article-title":"Interaction of measles virus vectors with Auger electron emitting radioisotopes","volume":"337","author":"Dingli","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.exphem.2006.03.002_bib11","doi-asserted-by":"crossref","first-page":"4919","DOI":"10.1158\/0008-5472.CAN-04-0884","article-title":"High CD46 receptor density on tumor cells leads to preferential killing by oncolytic measles virus","volume":"64","author":"Anderson","year":"2004","journal-title":"Cancer Res"},{"key":"10.1016\/j.exphem.2006.03.002_bib12","first-page":"45","article-title":"Membrane cofactor protein","volume":"178","author":"Liszewski","year":"1992","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.exphem.2006.03.002_bib13","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1111\/j.1365-2141.1992.tb06431.x","article-title":"Levels of complement regulatory proteins, CD35 (CR1), CD46 (MCP) and CD55 (DAF) in human haematological malignancies","volume":"82","author":"Hara","year":"1992","journal-title":"Br J Haematol"},{"key":"10.1016\/j.exphem.2006.03.002_bib14","doi-asserted-by":"crossref","first-page":"238","DOI":"10.4049\/jimmunol.145.1.238","article-title":"Quantitative analysis of membrane cofactor protein (MCP) of complement. High expression of MCP on human leukemia cell lines, which is down-regulated during cell differentiation","volume":"145","author":"Seya","year":"1990","journal-title":"J Immunol"},{"key":"10.1016\/j.exphem.2006.03.002_bib15","doi-asserted-by":"crossref","first-page":"2808","DOI":"10.1002\/1097-0142(19940601)73:11<2808::AID-CNCR2820731125>3.0.CO;2-P","article-title":"Protection of thyroid cancer cells by complement-regulatory factors","volume":"73","author":"Yamakawa","year":"1994","journal-title":"Cancer"},{"key":"10.1016\/j.exphem.2006.03.002_bib16","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1111\/j.1699-0463.1998.tb00233.x","article-title":"The complement regulatory proteins CD46 and CD59, but not CD55, are highly expressed by glandular epithelium of human breast and colorectal tumour tissues","volume":"106","author":"Thorsteinsson","year":"1998","journal-title":"APMIS"},{"key":"10.1016\/j.exphem.2006.03.002_bib17","first-page":"1039","article-title":"Expression of CD46, CD55, and CD59 on renal tumor cell lines and their role in preventing complement-mediated tumor cell lysis","volume":"74","author":"Gorter","year":"1996","journal-title":"Lab Invest"},{"key":"10.1016\/j.exphem.2006.03.002_bib18","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1002\/(SICI)1096-9098(199703)64:3<222::AID-JSO9>3.0.CO;2-C","article-title":"Frequent expression of complement resistance factors CD46, CD55, and CD59 on gastrointestinal cancer cells limits the therapeutic potential of monoclonal antibody 17-1A","volume":"64","author":"Juhl","year":"1997","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.exphem.2006.03.002_bib19","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1038\/sj.bjc.6690604","article-title":"Expression of membrane cofactor protein (MCP, CD46) in human liver diseases","volume":"80","author":"Kinugasa","year":"1999","journal-title":"Br J Cancer"},{"key":"10.1016\/j.exphem.2006.03.002_bib20","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1006\/gyno.1999.5614","article-title":"Expression of complement regulatory proteins\u2014CD 35, CD 46, CD 55, and CD 59\u2014in benign and malignant endometrial tissue","volume":"76","author":"Murray","year":"2000","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.exphem.2006.03.002_bib21","first-page":"1455","article-title":"Expression of the complement regulatory proteins decay accelerating factor (DAF, CD55), membrane cofactor protein (MCP, CD46) and CD59 in the normal human uterine cervix and in premalignant and malignant cervical disease","volume":"151","author":"Simpson","year":"1997","journal-title":"Am J Pathol"},{"key":"10.1016\/j.exphem.2006.03.002_bib22","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/(SICI)1097-0215(19970106)70:1<14::AID-IJC3>3.0.CO;2-9","article-title":"Complement-regulatory proteins in ovarian malignancies","volume":"70","author":"Bjorge","year":"1997","journal-title":"Int J Cancer"},{"key":"10.1016\/j.exphem.2006.03.002_bib23","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/labinvest.3780038","article-title":"A possible role of CD46 for the protection in vivo of human renal tumor cells from complement-mediated damage","volume":"80","author":"Blok","year":"2000","journal-title":"Lab Invest"},{"key":"10.1016\/j.exphem.2006.03.002_bib24","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1046\/j.1365-2249.1998.00581.x","article-title":"Human lung cancer cell lines express cell membrane complement inhibitory proteins and are extremely resistant to complement-mediated lysis; a comparison with normal human respiratory epithelium in vitro, and an insight into mechanism(s) of resistance","volume":"113","author":"Varsano","year":"1998","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.exphem.2006.03.002_bib25","doi-asserted-by":"crossref","first-page":"9928","DOI":"10.1128\/JVI.74.21.9928-9936.2000","article-title":"Recombinant measles viruses efficiently entering cells through targeted receptors","volume":"74","author":"Schneider","year":"2000","journal-title":"J Virol"},{"key":"10.1016\/j.exphem.2006.03.002_bib26","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1128\/JVI.75.5.2087-2096.2001","article-title":"Single chain antibody displayed on a recombinant measles virus confers entry through the tumor associated carcinoembryonic antigen","volume":"75","author":"Hammond","year":"2001","journal-title":"J Virol"},{"key":"10.1016\/j.exphem.2006.03.002_bib27","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1182\/blood.V99.5.1745","article-title":"Global gene expression profiling of multiple myeloma, monoclonal gammopathy of undetermined significance, and normal bone marrow plasma cells","volume":"99","author":"Zhan","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2006.03.002_bib28","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jim.2005.04.016","article-title":"Affinity ranking of antibodies using flow cytometry: application in antibody phage display-based target discovery","volume":"302","author":"Geuijen","year":"2005","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.exphem.2006.03.002_bib29","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0161-5890(03)00112-3","article-title":"Obstacles to cancer immunotherapy: expression of membrane complement regulatory proteins (mCRPs) in tumors","volume":"40","author":"Fishelson","year":"2003","journal-title":"Mol Immunol"},{"key":"10.1016\/j.exphem.2006.03.002_bib30","first-page":"959","article-title":"Immunization against tumor cell surface complement-regulatory proteins","volume":"2","author":"Durrant","year":"2001","journal-title":"Curr Opin Investig Drugs"},{"key":"10.1016\/j.exphem.2006.03.002_bib31","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1034\/j.1600-065X.2001.1800116.x","article-title":"Targeting complement in therapy","volume":"180","author":"Kirschfink","year":"2001","journal-title":"Immunol Rev"},{"key":"10.1016\/j.exphem.2006.03.002_bib32","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1038\/nm952","article-title":"CD46 is a cellular receptor for group B adenoviruses","volume":"9","author":"Gaggar","year":"2003","journal-title":"Nat Med"},{"key":"10.1016\/j.exphem.2006.03.002_bib33","doi-asserted-by":"crossref","first-page":"3897","DOI":"10.1128\/JVI.78.8.3897-3905.2004","article-title":"Membrane cofactor protein is a receptor for adenoviruses associated with epidemic keratoconjunctivitis","volume":"78","author":"Wu","year":"2004","journal-title":"J Virol"},{"key":"10.1016\/j.exphem.2006.03.002_bib34","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1002\/ijc.20129","article-title":"Modified adenoviruses for cancer gene therapy","volume":"110","author":"Kanerva","year":"2004","journal-title":"Int J Cancer"},{"key":"10.1016\/j.exphem.2006.03.002_bib35","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/j.ymthe.2003.07.006","article-title":"The effect of sequestration by nontarget tissues on anti-tumor efficacy of systemically applied, conditionally replicating adenovirus vectors","volume":"8","author":"Bernt","year":"2003","journal-title":"Mol Ther"},{"key":"10.1016\/j.exphem.2006.03.002_bib36","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/S1525-0016(03)00200-4","article-title":"Enhanced therapeutic efficacy for ovarian cancer with a serotype 3 receptor\u2013targeted oncolytic adenovirus","volume":"8","author":"Kanerva","year":"2003","journal-title":"Mol Ther"},{"key":"10.1016\/j.exphem.2006.03.002_bib37","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1038\/89901","article-title":"Replication-selective virotherapy for cancer: biological principles, risk management and future directions","volume":"7","author":"Kirn","year":"2001","journal-title":"Nat Med"},{"key":"10.1016\/j.exphem.2006.03.002_bib38","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1038\/sj.cgt.7700535","article-title":"RNA viruses as virotherapy agents","volume":"9","author":"Russell","year":"2002","journal-title":"Cancer Gene Ther"},{"key":"10.1016\/j.exphem.2006.03.002_bib39","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/nri888","article-title":"Viruses and interferon: a fight for supremacy","volume":"2","author":"Katze","year":"2002","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.exphem.2006.03.002_bib40","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S1357-2725(98)00136-8","article-title":"PKR, apoptosis and cancer","volume":"31","author":"Jagus","year":"1999","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.exphem.2006.03.002_bib41","doi-asserted-by":"crossref","first-page":"7635","DOI":"10.1128\/JVI.77.13.7635-7644.2003","article-title":"STAT protein interference and suppression of cytokine signal transduction by measles virus V protein","volume":"77","author":"Palosaari","year":"2003","journal-title":"J Virol"},{"key":"10.1016\/j.exphem.2006.03.002_bib42","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0014-5793(03)00528-3","article-title":"Measles virus V protein blocks interferon (IFN)-\u03b1\/\u03b2 but not IFN-\u03b3 signaling by inhibiting STAT1 and STAT2 phosphorylation","volume":"545","author":"Takeuchi","year":"2003","journal-title":"FEBS Lett"},{"key":"10.1016\/j.exphem.2006.03.002_bib43","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0042-6822(02)00026-0","article-title":"Measles virus suppresses interferon-\u03b1 signaling pathway: suppression of Jak1 phosphorylation and association of viral accessory proteins, C and V, with interferon-\u03b1 receptor complex","volume":"306","author":"Yokota","year":"2003","journal-title":"Virology"},{"key":"10.1016\/j.exphem.2006.03.002_bib44","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S0042-6822(03)00537-3","article-title":"The C protein of measles virus inhibits the type I interferon response","volume":"315","author":"Shaffer","year":"2003","journal-title":"Virology"},{"key":"10.1016\/j.exphem.2006.03.002_bib45","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1034\/j.1600-0609.2000.9r233.x","article-title":"Novel therapeutic targets in multiple myeloma","volume":"64","author":"Davies","year":"2000","journal-title":"Eur J Haematol"}],"container-title":["Experimental Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X06001378?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X06001378?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T08:21:30Z","timestamp":1759566090000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301472X06001378"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,6]]},"references-count":45,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2006,6]]}},"alternative-id":["S0301472X06001378"],"URL":"https:\/\/doi.org\/10.1016\/j.exphem.2006.03.002","relation":{},"ISSN":["0301-472X"],"issn-type":[{"value":"0301-472X","type":"print"}],"subject":[],"published":{"date-parts":[[2006,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oncolytic measles virus targets high CD46 expression on multiple myeloma cells","name":"articletitle","label":"Article Title"},{"value":"Experimental Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exphem.2006.03.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 International Society for Experimental Hematology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}